Guía de Práctica Clínica sobre Lupus Eritematoso Sistémico

688 Kuhn A, Gensch K, Haust M, Schneider SW, Bonsmann G, Gaebelein-Wissing N et al.
Efficacy of tacrolimus 0.1% ointment in cutaneous lupus erythematosus: a multicenter,
randomized, double-blind, vehicle-controlled trial. J Am Acad Dermatol 2011; 65: 54–64.
689 Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R et al. International
consensus statement on an update of the classification criteria for definite
antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295–306.
690 Wahl D, Guillemin F, de Maistre E, Perret C, Lecompte T, Thibaut G. Risk for venous
thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus A
meta-analysis. Lupus 1997; 6: 467–473.
691 Bruce IN. ‘Not only...but also’: factors that contribute to accelerated atherosclerosis and
premature coronary heart disease in systemic lupus erythematosus. Rheumatology
(Oxford) 2005; 44: 1492–1502.
692 Ruiz-Irastorza G, Cuadrado MJ, Ruiz-Arruza I, Brey R, Crowther M, Derksen R et al.
Evidence-based recommendations for the prevention and long-term management of
thrombosis in antiphospholipid antibody-positive patients: report of a task force at the
13th International Congress on antiphospholipid antibodies. Lupus 2011; 20: 206–218.
693 Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta M a. Clinical efficacy and
side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann
Rheum Dis 2010; 69: 20–28.
694 Arnaud L, Mathian A, Ruffatti A, Erkan D, Tektonidou M, Cervera R et al. Efficacy of
aspirin for the primary prevention of thrombosis in patients with antiphospholipid
antibodies: an international and collaborative meta-analysis. Autoimmun Rev 2014; 13:
281–291.
695 Petri M. Systemic lupus erythematosus and pregnancy. Rheum Dis Clin North Am 1994;
20: 87–118.
696 Derksen R, Bruinse H, de Groot P, Kater L. Pregnancy in systemic lupus erythematosus: a
prospective study. Lupus 1994; 3: 149–155.
697 Ruiz-Irastorza G, Khamashta M a. Lupus and pregnancy: integrating clues from the bench
and bedside. Eur J Clin Invest 2011; 41: 672–678.
698 Smyth A, Oliveira GHM, Lahr BD, Bailey KR, Norby SM, Garovic VD. A systematic
review and meta-analysis of pregnancy outcomes in patients with systemic lupus
erythematosus and lupus nephritis. Clin J Am Soc Nephrol 2010; 5: 2060–2068.
699 Le Thi D, Wescgler B, Piette J, Bletry O, Godeau P. Pregnancy and its outcome in
systemic lupus erythematosus. QJM An Int J Med 1994; 87: 721–729.
700 Clowse MEB, Magder LS, Witter F, Petri M. The impact of increased lupus activity on
obstetric outcomes. Arthritis Rheum 2005; 52: 514–521.
701 Brucato A, Frassi M, Franceschini F, Cimaz R, Faden D, Vignati G et al. Risk of
Congenital Complete Heart Block in Newborns of Mothers With Anti-Ro / SSA
GUÍA DE PRÁCTICA CLÍNICA SOBRE LUPUS ERITEMATOSO SISTÉMICO 487